177 related articles for article (PubMed ID: 26495412)
1. Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.
Rodriguez JA; Huerta-Yepez S; Law IK; Baay-Guzman GJ; Tirado-Rodriguez B; Hoffman JM; Iliopoulos D; Hommes DW; Verspaget HW; Chang L; Pothoulakis C; Baritaki S
Cell Mol Gastroenterol Hepatol; 2015 Nov; 1(6):610-630. PubMed ID: 26495412
[TBL] [Abstract][Full Text] [Related]
2. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
Pothoulakis C; Torre-Rojas M; Duran-Padilla MA; Gevorkian J; Zoras O; Chrysos E; Chalkiadakis G; Baritaki S
Int J Cancer; 2018 Jan; 142(2):334-346. PubMed ID: 28929494
[TBL] [Abstract][Full Text] [Related]
3. Urocortin 2 But Not Urocortin 3 Promotes the Synaptic Formation in Hipppocampal Neurons via Induction of NGF Production by Astrocytes.
Zheng Y; Zhang YM; Ni X
Endocrinology; 2016 Mar; 157(3):1200-10. PubMed ID: 26713785
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
Jin L; Li C; Li R; Sun Z; Fang X; Li S
J Mol Endocrinol; 2014 Jun; 52(3):255-67. PubMed ID: 24776847
[TBL] [Abstract][Full Text] [Related]
5. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.
Hoffman JM; Baritaki S; Ruiz JJ; Sideri A; Pothoulakis C
Am J Pathol; 2016 Jan; 186(1):134-44. PubMed ID: 26597886
[TBL] [Abstract][Full Text] [Related]
8. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.
Im E; Rhee SH; Park YS; Fiocchi C; Taché Y; Pothoulakis C
Gastroenterology; 2010 Jun; 138(7):2457-67, 2467.e1-5. PubMed ID: 20206175
[TBL] [Abstract][Full Text] [Related]
12. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
[TBL] [Abstract][Full Text] [Related]
13. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.
Moss AC; Anton P; Savidge T; Newman P; Cheifetz AS; Gay J; Paraschos S; Winter MW; Moyer MP; Karalis K; Kokkotou E; Pothoulakis C
Gut; 2007 Sep; 56(9):1210-7. PubMed ID: 17412781
[TBL] [Abstract][Full Text] [Related]
14. Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity.
Flaherty SE; Bezy O; Zheng W; Yan D; Li X; Jagarlapudi S; Albuquerque B; Esquejo RM; Peloquin M; Semache M; Mancini A; Kang L; Drujan D; Breitkopf SB; Griffin JD; Jean Beltran PM; Xue L; Stansfield J; Pashos E; Shakey Q; Pehmøller C; Monetti M; Birnbaum MJ; Fortin JP; Wu Z
Nat Commun; 2023 Jul; 14(1):3953. PubMed ID: 37402735
[TBL] [Abstract][Full Text] [Related]
15. SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.
Hu TH; Yao Y; Yu S; Han LL; Wang WJ; Guo H; Tian T; Ruan ZP; Kang XM; Wang J; Wang SH; Nan KJ
Cancer Lett; 2014 Nov; 354(2):417-26. PubMed ID: 25150783
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced changes in gene expression of urocortin 2 and other CRH peptides in rat adrenal medulla: involvement of glucocorticoids.
Tillinger A; Nostramo R; Kvetnansky R; Serova L; Sabban EL
J Neurochem; 2013 Apr; 125(2):185-92. PubMed ID: 23320836
[TBL] [Abstract][Full Text] [Related]
18. NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.
Han B; Zhang YY; Xu K; Bai Y; Wan LH; Miao SK; Zhang KX; Zhang HW; Liu Y; Zhou LM
Am J Cancer Res; 2018; 8(5):810-823. PubMed ID: 29888104
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
20. Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma.
Wang JJ; Chong QY; Sun XB; You ML; Pandey V; Chen YJ; Zhuang QS; Liu DX; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Nov; 8(61):103900-103918. PubMed ID: 29262609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
